UTRS MINERVA SURGICAL INC

Minerva Surgical Announces Time To Talk Campaign

Minerva Surgical Announces Time To Talk Campaign

Social Media Campaign and Event Series Encourage Women to Talk Openly About Their Periods

SANTA CLARA, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. – The Uterine Health Company (Nasdaq: UTRS), focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced their Time To Talk social media campaign and local event series.

Abnormal Uterine Bleeding, or AUB, is a common medical condition affecting 1 in 3 women1 that results in heavy periods and uterine bleeding outside the normal duration, regularity, or frequency. AUB encompasses a variety of causes and symptoms that can leave women feeling as if life revolves around their period.

The Clinical Education team at Minerva recently began hosting Time To Talk…LIVE in person events. Together with local gynecology practices, the team invites those who have questions about their period to attend open, informational conversations about all things period.

Dr. Elizabeth Roth and Dr. Kent Meldrum from May-Grant Obstetrics & Gynecology spoke at the inaugural Time To Talk…LIVE event on July 19 in Lancaster, PA. Dr. Roth stressed the importance of talking about your period. She stated, “We are here to help you. Open communication with your physician is key to getting your heavy period treated.”

Upcoming events include locations in Suwanee, GA, Wheeling, WV, Morgantown, WV and Lancaster, OH. We encourage you to come as you are for a casual conversation with a doctor that specializes in AUB near you. If you are interested in holding a Time To Talk…LIVE event in your area, contact Minerva at .

“We strongly encourage anyone who thinks they may be living with AUB to talk to an OBGYN who understands the condition. Attending a Time To Talk…LIVE event is a fantastic first step in initiating the discussion,” said Mike Clapper, Director of Brand Strategy at Market Development at Minerva Surgical.

Supporters can join the conversation using #TimeToTalkAUB. Visit to understand the symptoms, causes and minimally invasive treatment options for Abnormal Uterine Bleeding.

  1. Davis E, Sparzak PB. Abnormal Uterine Bleeding. [Updated 2022 Feb 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Accessed July 14, 2022, from

About Minerva Surgical, Inc. – The Uterine Health Company

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

MEDIA CONTACT

Mike Clapper



804-295-7676

INVESTOR RELATIONS CONTACT

Caroline Corner



415-202-5678

RELATED LINKS





EN
03/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MINERVA SURGICAL INC

 PRESS RELEASE

Minerva Surgical Reports Third Quarter 2023 Financial Results

Minerva Surgical Reports Third Quarter 2023 Financial Results SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023. Third Quarter Highlights: Reported revenue of $12.0 million in the third quarter of 2023, compared with revenue of $12.6 million in the third quarter of 2022Increased Symphion product revenue by 19% compared t...

 PRESS RELEASE

Minerva Surgical Reports First Quarter 2023 Financial Results

Minerva Surgical Reports First Quarter 2023 Financial Results SANTA CLARA, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported first quarter financial results for the period ended March 31, 2023. First Quarter and Recent Business Highlights: Reported revenue of $12.5 million in the first quarter of 2023, compared with revenue of $10.9 million in the first quarter of 2022Increased revenue for all product lines c...

 PRESS RELEASE

Minerva Surgical to Announce First Quarter 2023 Financial Results

Minerva Surgical to Announce First Quarter 2023 Financial Results SANTA CLARA, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a medical technology company focused on solutions to meet the distinct uterine healthcare needs of women, announced today that it will release its first quarter 2023 financial results on Tuesday, May 2, 2023. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. To access the live call...

 PRESS RELEASE

Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Co...

Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief Commercial Officer. Ms. Zagger’s leadership will help guide the strategic growth of the company and advance its position as a leader in women’s healthcare solutions. “We are excited to have Kaile as our new Chief Commercial Of...

 PRESS RELEASE

Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial R...

Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported fourth quarter and full-year financial results for the period ended December 31, 2022. Fourth Quarter and Recent Business Highlights: Reported revenue of $13.8 million in the fourth quarter of 2022, compared with revenue of $13.6 million in the fourth quarter of 2021 an...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch